What's new in the treatment of advanced prostate cancer?

被引:21
作者
Sternberg, CN [1 ]
机构
[1] San Camillo Forlanini Hosp, Vincenzo Pansadoro Fdn, Dept Med Oncol, I-00165 Rome, Italy
关键词
prostate cancer; treatment; hormone-refractory; second-line; immunotherapy; chemotherapy; gene therapy; new agents;
D O I
10.1016/S0959-8049(02)00665-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increased insight into the biology of prostate cancer and the emergence of new therapeutic strategies and chemotherapeutic agents has changed approaches in treating patients with advanced prostate cancer. After secondary hormonal manipulations, new approaches include: second-line hormonal therapy, chemotherapy, immunotherapy with granulocyte macrophage-colony stimulating factor (GM-CSF) therapy, dendritic cell therapy, gene vaccination therapy, inhibition and/or blockade of growth factor receptors or growth factor receptor pathways, inhibition of neo-angiogenesis and inhibition of invasion and metastases. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:136 / 146
页数:11
相关论文
共 112 条
[1]   A potential role for activated HER-2 in prostate cancer [J].
Agus, DB ;
Akita, RW ;
Fox, WD ;
Lofgren, JA ;
Higgins, B ;
Maiese, K ;
Scher, HI ;
Sliwkowski, MX .
SEMINARS IN ONCOLOGY, 2000, 27 (06) :76-83
[2]  
AHMANN FR, 2001, P AN M AM SOC CLIN, V20, P692
[3]   Growth factors and their receptors: New targets for prostate cancer therapy [J].
Barton, J ;
Blackledge, G ;
Wakeling, A .
UROLOGY, 2001, 58 (2A) :114-122
[4]  
BEER TM, 2000, P AN M AM SOC CLIN, V19, pA348
[5]   Society of urologic oncology biotechnology forum: New approaches and targets for advanced prostate cancer [J].
Belldegrun, A ;
Bander, NH ;
Lerner, SP ;
Wood, DP ;
Pantuck, AJ .
JOURNAL OF UROLOGY, 2001, 166 (04) :1316-1321
[6]  
Berenson JR, 2001, SEMIN ONCOL, V28, P25
[7]  
BERRY W, 2001, P AN M AM SOC CLIN, V20, pA175
[8]  
BOISSIER S, 2000, CANCER RES, V60, P2954
[9]  
Bok RA, 2001, CANCER RES, V61, P2533
[10]  
Chatterjee D, 2000, ANTICANCER RES, V20, P2885